An UK expert panel has issued a report recommending that patients taking antibiotics, especially those being treated in hospital, should take a clinically-proven daily probiotic drink. At a meeting which took place at the Royal Society of Medicine, London, a panel of eight health experts discussed data on the health benefits of dairy probiotic drinks, and concluded they should be taken by people on antibiotics in hospital as well as the community setting.
Antibiotics can disrupt the normal balance of bacteria living in the intestine, making it easier for harmful bacteria to grow, which is why diarrhea is a common side effect of antibiotics, especially when administered in hospitals where 5%-30% of patients develop this symptom, the rate increasing with broader-spectrum antibiotics. The effect on the patient may include a longer hospital stay, an increased risk of other infections and diseases, as well as significant increases to the costs of patient care.
Probiotics are drinks containing live micro-organisms which confer a health benefit on the host and include Streptococcus thermophilus, Enterococcus species, Saccharomyces species, and various species of lactobacilli and bifidobacteria. Lactobacilli, bifidobacteria, and Streptococcus species have all been clinically evaluated for the prevention or treatment of diarrhea associated with antibiotic use and found to be safe.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze